These results indicate that activation of LRH‐1 may ameliorate podocyte injury and shedding by enhancing GLS2‐mediated glutaminolysis and improving the ability of mitochondria energy metabolism in podocytes under DKD. This evidence concerns the gene GLS2 and diabetic kidney disease.